Trial Details

UNKNOWN
Basic Information
Clinical ID c1659
Identifier NCT05196958
Trial Title Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases|Diabetes Mellitus, Type 2
Interventions OTHER: GLP1 analogues
Participant Information
Sponsor Fondation H么pital Saint-Joseph
City Paris
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2022-01-25
Primary Completion Date 2024-01-14
Completion Date 2024-12-31